RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 85 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36,614,045 | +39.0% | 1,597,123 | 0.0% | 0.98% | +56.5% |
Q2 2023 | $26,336,558 | -7.6% | 1,597,123 | 0.0% | 0.63% | -7.8% |
Q1 2023 | $28,492,674 | -44.4% | 1,597,123 | -9.3% | 0.68% | -44.9% |
Q4 2022 | $51,276,389 | +18.9% | 1,760,865 | 0.0% | 1.23% | +10.8% |
Q3 2022 | $43,141,000 | +640.7% | 1,760,865 | +25.5% | 1.11% | +559.2% |
Q2 2022 | $5,824,000 | -59.1% | 1,403,298 | +13.4% | 0.17% | -52.9% |
Q1 2022 | $14,251,000 | +127.7% | 1,237,026 | +97.2% | 0.36% | +147.6% |
Q4 2021 | $6,259,000 | -21.7% | 627,180 | +2.5% | 0.14% | -13.7% |
Q3 2021 | $7,995,000 | -32.7% | 612,180 | +1.0% | 0.17% | -28.5% |
Q2 2021 | $11,871,000 | -6.9% | 606,280 | +1.2% | 0.24% | -15.5% |
Q1 2021 | $12,747,000 | -12.6% | 599,280 | +22.2% | 0.28% | -10.0% |
Q4 2020 | $14,578,000 | +45.0% | 490,339 | +5.7% | 0.31% | +21.2% |
Q3 2020 | $10,057,000 | -11.9% | 464,086 | -9.4% | 0.26% | -18.5% |
Q2 2020 | $11,420,000 | +50.1% | 512,111 | +2.4% | 0.31% | -0.6% |
Q1 2020 | $7,610,000 | -3.9% | 500,000 | +44.9% | 0.32% | +26.0% |
Q4 2019 | $7,921,000 | +20.3% | 345,000 | +13.1% | 0.25% | -4.6% |
Q3 2019 | $6,585,000 | +27.4% | 305,000 | +29.8% | 0.26% | +40.1% |
Q2 2019 | $5,170,000 | -12.9% | 235,000 | +8.5% | 0.19% | -18.3% |
Q1 2019 | $5,934,000 | +2.0% | 216,500 | 0.0% | 0.23% | -16.7% |
Q4 2018 | $5,820,000 | -7.2% | 216,500 | +0.7% | 0.28% | +21.1% |
Q3 2018 | $6,272,000 | -6.7% | 215,000 | 0.0% | 0.23% | -12.4% |
Q2 2018 | $6,721,000 | +372.3% | 215,000 | +200.7% | 0.26% | +324.6% |
Q1 2018 | $1,423,000 | -31.5% | 71,500 | 0.0% | 0.06% | -35.1% |
Q4 2017 | $2,078,000 | – | 71,500 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |